Skip to main content
Equibles

MIC Capital Management UK LLP

Position in NMRA — Neumora Therapeutics, Inc.

CIK 1889830 LONDON, X0
Back to NMRA Full portfolio

Position in NMRA

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$7,583,190
-$1,115,174 QoQ
Shares Held
4,460,700
0.0% QoQ
Ownership
2.37%
of shares outstanding
% of Portfolio
1.92%
of 13F equity value
Holder Rank
#5
of 111 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NMRA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MIC Capital Management UK LLP holds $143,782,490 across 4 Biotechnology names. NMRA ranks #3 (5.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 531,733 $99,582,956
2 RXRX
Recursion Pharmaceuticals, Inc.
 9,644,033 $35,393,601
3 NMRA
Neumora Therapeutics, Inc.
This page 		4,460,700 $7,583,190
4 LYEL
Lyell Immunopharma, Inc.
 87,028 $1,222,743

All Filings in NMRA

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,583,190 4,460,700
2026-03-31 $8,698,364 4,460,700
2025-12-31 $7,984,653 4,460,700
2025-09-30 $8,118,474 4,460,700
2025-06-30 $3,269,692 4,460,700
2025-03-31 $4,460,700 4,460,700
2024-12-31 $47,283,420 4,460,700
2024-09-30 $58,925,847 4,460,700
2024-06-30 $43,848,681 4,460,700
2024-03-31 $61,334,624 4,460,700
2023-12-31 $76,054,935 4,460,700
2023-09-30 $62,940,476 4,460,700